NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD
  • XY Feed
  • 24-HOUR Pass ↗
  • Push Notifications
Sign in Subscribe

Guidewire Shares Drop After Current-Quarter Sales Outlook Misses Estimates

Q4 revenue and EPS beat estimates, but Guidewire’s $372–$378 million Q1 sales guide trailed Wall Street and weighed on the stock.

Guidewire Shares Drop After Current-Quarter Sales Outlook Misses Estimates
Credit: Guidewire
Already have an account? Sign in.
09/03/2026 · 6:10 PM
GWRE
/ Don’t stop at just one post.

Related↓

Guidewire Beats Revenue & EPS Forecasts, But Stock Falls on Full-Year ARR Outlook
06/05/2026 · 6:38 AM

Guidewire Beats Revenue & EPS Forecasts, But Stock Falls on Full-Year ARR Outlook

Guidewire beat Q3 earnings, but a weak ARR outlook worried investors, sending shares down despite strong revenue growth.

/ Subscriber only
/ Read more

Feed↓

Instacart in Preliminary Talks for Potential Sale, DoorDash and Uber Involved
Featured/ 10/23/2026 · 4:22 PM

Instacart in Preliminary Talks for Potential Sale, DoorDash and Uber Involved

Instacart is exploring a sale that could value the company at $16–17 billion, with preliminary talks involving DoorDash and Uber.

/ Subscriber only
Scotiabank Sees Bargain in AST SpaceMobile After 70% Drop, Upgrades Stock
Featured/ 10/23/2026 · 3:41 PM

Scotiabank Sees Bargain in AST SpaceMobile After 70% Drop, Upgrades Stock

Analysts upgrade AST SpaceMobile to Outperform after a sharp drop. Scotiabank cites SpaceX competition but sees value in AST’s wholesale 5G model.

/ Subscriber only
Corcept Faces New Competitive Pressure as Genmab’s Rina-S Shows Broad Benefit in Platinum-Resistant Ovarian Cancer
10/23/2026 · 2:44 PM

Corcept Faces New Competitive Pressure as Genmab’s Rina-S Shows Broad Benefit in Platinum-Resistant Ovarian Cancer

Rina-S shows significant PFS and OS gains in platinum-resistant ovarian cancer, challenging Corcept’s Lifyorli position.

/ Subscriber only
Explore
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD
  • XY Feed
  • 24-HOUR Pass ↗
  • Push Notifications
More
  • Sign up
  • Sign in
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Terms/Privacy
  • UP↑
Get alerts

Be the first to know when deals break, stocks move, or biotech headlines hit.

Email address Subscribe
DON'T FALL BEHIND. ©2026
For informational purposes only. Not financial advice.
NOTRELOAD AI